Inve India ▾

Unihealth Hosp share price & results

Unihealth Hosp· Healthcare

Results to
Mar 2026
Latest analysed call
Q4 FY26
Ownership as of
Sept 2026

Healthcare group running 'UMC Hospitals' multi-specialty tertiary-care hospitals and dialysis centres in Uganda, Tanzania and India, plus hospital consultancy, medical-product distribution and medical value-travel services.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue65.0 ₹ crore+16.1% YoYQuarterly, as filedQuarter to Mar 2026Revenue from operations as filed.
Operating margin34.0 %−4.0 pts YoYOperating profit / revenueQuarter to Mar 2026For the quarter; a change is in percentage points.
Net profit17.0 ₹ crore−5.6% YoYQuarterly, as filedQuarter to Mar 2026Profit after tax as filed.
Return on equityUnavailable+6.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.
Free cash flow margin-19.11 %−5.8 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)Unavailable−68.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Mar 2026

Guidance

What management said, and what became of it

1 of 2 judged targets kept · 14 open · verdicts reflect calls analysed to Q4 FY26.

Unihealth Hosp management guidance track record on Inve: 16 targets tracked across analysed earnings calls (1 achieved, 1 missed, 14 open).

TargetOriginal wordingSaidLatest callVerdict
Navi Mumbai Hospital Operational StartExpected to begin operations by July 2025
Call transcript, Q4 FY25 · 26 May 2025
Q4 FY25Q4 FY26:Facility became fully operational in mid-February 2026. This fulfills the promise, though later than the original July 2025 target.
Call transcript, Q4 FY26 · 3 Jun 2026
Achieved
Uganda ARPOB55,000 to 60,000 in the next 12 months
Call transcript, Q2 FY26 · 18 Nov 2025
Q2 FY26Q4 FY26:No update provided on the current Uganda ARPOB or progress towards the 55k-60k target set for the next 12 months (by Q2 FY27).
Call transcript, Q4 FY26 · 3 Jun 2026
Ghosted
Total Operational BedsCross 1,000 commissioned and operational beds under India and East Africa in the coming 3 years
Call transcript, Q4 FY25 · 26 May 2025
Q4 FY25Q4 FY26:Target timeline pushed from CY27 to CY28. Company now targets 1,000 commissioned beds by CY28.
Call transcript, Q4 FY26 · 3 Jun 2026
Delayed

Source: Inve Guidance Tracker for Unihealth Hosp · to Q4 FY26

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

1 of Unihealth Hosp's 16 targets was missed. See which ones, and which are quietly gone. The 3 above are the free sample; 13 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹550 −0.18% · −₹1

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance +241.6% 1Y

₹200₹400₹600₹800Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 18 Nov 2025Q4 FY26 — 3 Jun 2026

1Y: ₹161 on 24 Oct 2025 → ₹550. High ₹807.35 (3 Aug 2026), low ₹155 (10 Nov 2025).

Previous close
₹551
Market cap
₹876 Cr
52-week range
₹155 – ₹807.35
One year
+234.86%
Price to earnings (FY ending Mar 2026)
33.69×
Return on equity (FY ending Mar 2026)
21.76%

Overview

Symbol
NSE:UNIHEALTH
Exchange
NSE
Currency
INR

What Unihealth Hosp does

Based on the company's own presentations, annual report and earnings calls.

UniHealth Hospitals Limited operates and manages multi-specialty tertiary-care hospitals and a dialysis centre under its 'UMC Hospitals' brand in Uganda and Tanzania, and has recently commissioned new hospitals in Navi Mumbai (operational) and Nashik (upcoming) in India. Alongside direct hospital operations, it runs a healthcare-consultancy vertical providing feasibility studies, hospital planning, project management and operations advisory to third-party healthcare projects in India and abroad. It also distributes and exports medical consumables and pharmaceuticals to African markets as an authorized distributor for companies such as Reliance Life Sciences and Fixderma India, and facilitates medical value travel for international patients seeking treatment at partner hospitals in India.

Segments

  • Hospitals & Medical Centres
  • Healthcare Consultancy
  • Distribution & Trade
  • Medical Value Travel
Operational hospital beds
~400 (doubled from ~200 at start of FY26)
Hospitals & medical facilities
UMC Victoria Hospital, Kampala, Uganda (120 beds, est. 2017); Unihealth Medical Centre dialysis facility, Mwanza, Tanzania (10 beds, est. 2016); Navi Mumbai hospital (52 beds, opened Oct 2025); Nashik hospital (200 beds, commissioning FY27); Entebbe, Uganda hospital (acquired FY26)
Countries of operation
3 (India, Uganda, Tanzania), after exiting Nigeria (UMC Zhahir Hospital, Kano)
Doctors & specialists
150+
Employees
500+
Patients treated annually
1,30,000+
Founded 2010Headquarters Mumbai, Maharashtra, India Company website

How the price took the results

close before → close after

Q4 FY26
+4.9%
3 Jun
Q2 FY26
+18.3%
18 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Unihealth Hosp

Free account: one company. Everything above stays public.

Write why you follow Unihealth Hosp and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds